Showing 2251-2260 of 5316 results for "".
A Case of Deductible Reasoning and Social Media Extortion
https://practicaldermatology.com/topics/practice-management/a-case-of-deductible-reasoning-and-social-media-extortion/21201/6 Tips to Stay Updated with Social Media Trends
https://practicaldermatology.com/topics/practice-management/6-tips-to-stay-updated-with-social-media-trends/21204/Staying on top of social media trends allows physicians to maintain a marketing edge.Recent Developments
https://practicaldermatology.com/columns/recent-developments/news/21265/Reduce Burnout
https://practicaldermatology.com/topics/practice-management/reduce-burnout/21320/Riding the teeter-totter of a healthy work-life balance.Home Devices: Do They Actually Work?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/home-devices-do-they-actually-work/21334/Although home devices may appeal to patients due to their convenience, often they fall short when it comes to sound science and optimal outcomes.I Object! Questions Facing Physicians' Rights to Dispute Sunshine Data
https://practicaldermatology.com/topics/general-topics/i-object-questions-facing-physicians-rights-to-dispute-sunshine-data/21351/Will your practice be prepared when CMS posts Sunshine disclosures later this year?DermwireTV — Valeant Ups Allergan Bid, Nestle Buys Injectables, and Allergan Makes Its Case
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-valeant-ups-allergan-bid-nestle-buys-injectables-and-allergan-makes-its-case/19128/BREAKING NEWS: Valeant has increased its offer for Allergan to $72 per share. Read more. Valeant sells the rights to its aesthetic injectables to Nestle, while Allergan touts physician support and challenges Valeant's business model. In this week's edition of DermWireTV, learn about Valeant's latesClinical Insights on Management of Comorbidities in the Psoriasis Patient
https://practicaldermatology.com/topics/psoriasis/clinical-insights-on-management-of-comorbidities-in-the-psoriasis-patient/21375/As psoriasis is associated with an increasing number of comorbidities, clinicians discuss their approach to management focused on the whole patient.Investigating the Potential for Neuromodulators in the Treatment of Psoriasis
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/investigating-the-potential-for-neuromodulators-in-the-treatment-of-psoriasis/21398/What's Hot in Cosmeceuticals
https://practicaldermatology.com/topics/practice-management/whats-hot-in-cosmeceuticals/21430/The expanding variety of cosmeceuticals allows dermatologists to address the specific needs and desires of patients.